Synapse - Ahmet Dogan

Results (470)

Breast implant-associated anaplastic large cell lymphoma: Clinical and imaging findings at a large US cancer center

Journal Article

Dashevsky, B. Z.; Gallagher, K. M.; Grabenstetter, A.; Cordeiro, P. G.; Dogan, A.; Morris, E. A.; Horwitz, S. M.; Sutton, E. J.
Breast Journal (2019)

Fulltext@MSK | Save

Angioimmunoblastic T-cell lymphoma

Journal Article

Yabe, M.; Dogan, A.; Horwitz, S. M.; Moskowitz, A. J.
Cancer Treatment and Research (2019)

Fulltext@MSK | Save

Histology of Rosai-Dorfman disease in a subset of patients with Erdheim-Chester disease: A distinct entity mainly driven by MAP2K1

Meeting Abstract

Razanamahery, J.; Diamond, E.; Cohen-Aubart, F.; Karl-Heinz, P.; Charlotte, F.; Helias-Rodzewicz, Z.; Dogan, A.; Abdel-Wahab, O.; Durham, B.; Ozkaya, N.; more...
Pediatric Blood and Cancer (2019)

Fulltext@MSK | Save

Histology of Rosai-Dorfman disease in a subset of patients with Erdheim-Chester disease: A distinct entity mainly driven by MAP2K1

Meeting Abstract

Razanamahery, J.; Diamond, E. L.; Plate, K.; Charlotte, F.; Hélias-Rodzewicz, Z.; Dogan, A.; Abdel-Wahab, O. I.; Durham, B. H.; Ozkaya, N.; Amoura, Z.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Functional proteomics for precise cancer diagnosis and therapy using the MSK Quantitative Cancer Proteomics Atlas

Meeting Abstract

Cifani, P.; Dogan, A.; Solit, D. B.; Kentsis, A.
Cancer Research (2018)

Fulltext@MSK | Save

Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial

Meeting Abstract

Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
Blood (2018)

Fulltext@MSK | Save

MRD-response driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m(2)) in combination with lenalidomide and dexamethasone

Meeting Abstract

Korde, N.; Mastey, D.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Tavitian, E.; Salcedo, M.; more...
Blood (2018)

Fulltext@MSK | Save

The combination of duvelisib, a PI3K-δ,γ inhibitor, and romidepsin is highly active in relapsed/refractory peripheral T-cell lymphoma with low rates of transaminitis: Results of parallel multicenter, phase 1 combination studies with expansion cohorts

Meeting Abstract

Horwitz, S. M.; Moskowitz, A. J.; Jacobsen, E. D.; Mehta-Shah, N.; Khodadoust, M. S.; Fisher, D. C.; Myskowski, P.; Wang, E. B. K.; Tawa, M.; Davey, T.; more...
Blood (2018)

Fulltext@MSK | Save

Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma

Journal Article

Kumar, A.; Vardhana, S.; Moskowitz, A. J.; Porcu, P.; Dogan, A.; Dubovsky, J. A.; Matasar, M. J.; Zhang, Z.; Younes, A.; Horwitz, S. M.
Blood Advances (2018)

Fulltext@MSK | Save

Durable responses observed with JAK inhibition in T-cell lymphomas

Meeting Abstract

Moskowitz, A. J.; Jacobsen, E.; Ruan, J.; Schatz, J. H.; Obadi, O.; Motylinski, K.; Jarjies, C.; Galasso, N.; Hancock, H.; Davey, T.; more...
Blood (2018)

Fulltext@MSK | Save